StapleBio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $2.98M

  • Investors
  • 6

StapleBio General Information

Description

Operator of a biotechnology platform designed to develop treatments for diseases by targeting cellular and molecular mechanisms. The company offers drug discovery, biological research, therapeutic development, and technology for identifying disease mechanisms and potential drug targets to precisely regulate gene expression, enabling pharmaceutical researchers to develop new medicines for conditions with limited treatment options.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2-39-1 Kurokami
  • Chuoku
  • Kumamoto, Kumamoto 860-8555
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2-39-1 Kurokami
  • Chuoku
  • Kumamoto, Kumamoto 860-8555
  • Japan

StapleBio Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

StapleBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 07-May-2024 $2.98M Completed Startup
2. Seed Round 16-Dec-2022 Completed Startup
1. Seed Round 20-Jan-2022 $609K $609K Completed Startup
To view StapleBio’s complete valuation and funding history, request access »

StapleBio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
S-Class Preferred
S3 Class Preferred
S2 Class Preferred 62,668 $7.23 $7.23 1x $7.23 15.83%
To view StapleBio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

StapleBio Patents

StapleBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2025083626-A Novel uses of staple nucleic acids Pending 21-Nov-2023

StapleBio Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Diamond Medino Capital Venture Capital Minority
Mitsubishi UFJ Capital Venture Capital Minority
Sumisho Pharma International Corporation Minority
Higin Capital Investment Bank Minority
KSP (Kawasaki) Corporation Minority
You’re viewing 5 of 6 investors. Get the full list »

StapleBio FAQs

  • When was StapleBio founded?

    StapleBio was founded in 2021.

  • Where is StapleBio headquartered?

    StapleBio is headquartered in Kumamoto, Japan.

  • What industry is StapleBio in?

    StapleBio’s primary industry is Drug Discovery.

  • Is StapleBio a private or public company?

    StapleBio is a Private company.

  • What is the current valuation of StapleBio?

    The current valuation of StapleBio is .

  • What is StapleBio’s current revenue?

    The current revenue for StapleBio is .

  • How much funding has StapleBio raised over time?

    StapleBio has raised $4.17M.

  • Who are StapleBio’s investors?

    Diamond Medino Capital, Mitsubishi UFJ Capital, Sumisho Pharma International, Higin Capital, and KSP (Kawasaki) are 5 of 6 investors who have invested in StapleBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process